Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Dmitriy V MaltsevDepartment of Pharmacology and Bioinformatics, Volgograd State Medical University, 400131 Volgograd, Russia.
Alexander A SpasovDepartment of Pharmacology and Bioinformatics, Volgograd State Medical University, 400131 Volgograd, Russia.ORCID 0000-0002-7185-4826
Pavel M VassilievDepartment of Pharmacology and Bioinformatics, Volgograd State Medical University, 400131 Volgograd, Russia.ORCID 0000-0002-8188-5052
Maria O SkripkaDepartment of Pharmacology and Bioinformatics, Volgograd State Medical University, 400131 Volgograd, Russia.ORCID 0000-0002-4173-7143
Mikhail V MiroshnikovDepartment of Pharmacology and Bioinformatics, Volgograd State Medical University, 400131 Volgograd, Russia.
Andrey N KochetkovLaboratory for Information Technology in Pharmacology and Computer Modeling of Drugs for Reasearch Center of Innovative Medicines, Volgograd Medical Scientific Center, 400131 Volgograd, Russia.
Nataliya V EliseevaDepartment of Pharmacology and Bioinformatics, Volgograd State Medical University, 400131 Volgograd, Russia.ORCID 0000-0002-2243-5326
Yuliya V LifanovaDepartment of Pharmacology and Bioinformatics, Volgograd State Medical University, 400131 Volgograd, Russia.
Tatyana A KuzmenkoResearch Institute of Physical and Organic Chemistry, Laboratory of organic synthesis, Southern Federal University, 344090 Rostov-on-Don, Russia.
Lyudmila N DivaevaResearch Institute of Physical and Organic Chemistry, Laboratory of organic synthesis, Southern Federal University, 344090 Rostov-on-Don, Russia.
Anatolii S MorkovnikResearch Institute of Physical and Organic Chemistry, Laboratory of organic synthesis, Southern Federal University, 344090 Rostov-on-Don, Russia.
Funding
Ministry of Science and Higher Education of the Russian Federation (State assignment in the field of scientific activity, Southern Federal University, 2020 FENW-2020-0031 (0852-2020-0031)Russian Foundation for Basic Research 20-015-00164
6 · The paper itself
Abstract
A number of novel 2,3,4,5-tetrahydro[1,3]diazepino[1,2-
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Synthesis and Pharmacological Evaluation of Novel 2,3,4,5-tetrahydro[1,3]diazepino[1,2- · full record | OpenQuestion